The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Sutro Biopharma Inc (NASDAQ: STRO) was $0.8 for the day, down -0.26%% from the previous closing price of $0.8. In other words, the price has decreased by -$0.26% from its previous closing price. On the day, 0.66 million shares were traded.
Ratios:
Our analysis of STRO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 2.16.
Wedbush Downgraded its Outperform to Neutral on March 14, 2025, whereas the target price for the stock was revised from $8 to $2.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.02.
Stock Price History:
Over the past 52 weeks, STRO has reached a high of $5.17, while it has fallen to a 52-week low of $0.52. The 50-Day Moving Average of the stock is -5.98%, while the 200-Day Moving Average is calculated to be -61.20%.
Shares Statistics:
A total of 84.35M shares are outstanding, with a floating share count of 78.04M. Insiders hold about 7.60% of the company’s shares, while institutions hold 67.16% stake in the company.
